Role of invasive and noninvasive testing in risk stratification of sudden cardiac death in children and young adults: An electrophysiologic perspective

Pediatric Clinics of North America

Volumn 51, Issue 5, 2004, Pages 1355-1378

  Attari, Mehran ^a   Dhala, Anwer ^a,b,c  

^a AURORA SINAI MEDICAL CENTER   (United States)

^b 9000 W Wisconsin Avenue 53226 ^*  (United States)

^c WI 53215 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; PROCAINAMIDE; SODIUM CHANNEL BLOCKING AGENT;

AGE DISTRIBUTION; BRUGADA SYNDROME; CARDIOVASCULAR RISK; CONGENITAL HEART DISEASE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TEST; FAMILY HISTORY; FOLLOW UP; GENETICS; HEART ARREST; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FUNCTION TEST; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE DYSPLASIA; HEMODYNAMICS; HOLTER MONITORING; HOSPITALIZATION; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LENGTH OF STAY; LONG QT SYNDROME; NON INVASIVE MEASUREMENT; PREDICTION; PROGNOSIS; QRS COMPLEX; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; STRATIFICATION; SUDDEN DEATH; SYNCOPE; T WAVE; VALIDATION PROCESS; WOLFF PARKINSON WHITE SYNDROME;

ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; LONG QT SYNDROME; RISK ASSESSMENT; SIGNAL PROCESSING, COMPUTER-ASSISTED; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 4344689722     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.04.007     Document Type: Review

References (117)

1. Wren C. Sudden death in children and adolescents. Heart. 88(4):2002;426-431
2. Corrado D., Basso C., Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 50:2001;399-408
3. Coumel P. Catecholaminergic polymorphic ventricular tachyarrhythmias in children. Card Electrophysiol Rev. 6:2002;93-95
4. Marks A.R. Clinical implications of cardiac ryanodine receptor/calcium release channel mutations linked to sudden cardiac death. Circulation. 106:2002;8-10
5. Stefanelli C.B., Bradley D.J., Leroy S., Dick M. II, Serwer G.A., Fischbach P.S. Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol. 6:2002;235-244
6. Pfammatter J.P., Bauersfeld U. Idiopathic ventricular tachycardias in infants and children. Card Electrophysiol Rev. 6:2002;88-92
7. Wren C. Sudden death in children and adolescents. Card Electrophysiol Rev. 5:2001;403-407
8. Kofflard M.J., Ten Cate F.J., van der Lee C., van Domburg R.T.J. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol. 41:2003;9879-9893
9. Brugada P., Brugada J., Brugada R. The Brugada syndrome. Card Electrophysiol Rev. 6:2002;45-48
10. Moss A.J., Schwartz P.J., Crampton R.S., Tzivoni D., Locati E.H., MacCluer J., et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 84:1991;1136-1144
11. Munger T.M., Packer D.L., Hammill S.C., Feldman B.J., Bailey K.R., Ballard D.J., et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation. 87:1993;866-873
12. Fontaine G., Fontaliran F., Iwa T., Aouate P., Naditch L., Lascault G., et al. Arrhythmogenic right ventricular dysplasia: definition and mechanism of sudden death. Akhtar M., Myerburg R., Ruskin J. Sudden cardiac death: prevalence, mechanisms, and approaches to diagnosis and management. 1994;215-225 Williams & Wilkins, Philadelphia
13. Al-Khatib S.M., LaPointe N.M., Kramer J.M., Califf R.M. What clinicians should know about the QT interval. JAMA. 289:2003;2120-2127
14. Moss A.J. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 72:1993;23B-25B
15. Schwartz P.J., Moss A.J., Vincent G.M., Cramptom R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 88:1993;782-784
16. Garson A. Jr., Dick M. II, Fournier A., Gillette P.C., Hamilton R., Kugler J.D., et al. The long QT syndrome in children. An international study of 287 patients. Circulation. 87:1993;1866-1872
17. Zareba W., Moss A.J., Locati E.H., Lehmann M.H., Peterson D.R., Hall W.J., et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol. 42:2003;103-109
18. Zhang L., Timothy K.W., Vincent G.M., Lehmann M.H., Fox J., Giuli L.C., et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 102:2000;2849-2855
19. Schwartz P.J., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 103:2001;89-95
20. Priori S.G., Napolitano C., Vicentini A. Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J Interv Card Electrophysiol. 2:2003;93-101
21. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., et al. Risk stratification in the long-QT syndrome. N Engl J Med. 348:2003;1866-1874
22. Gaita F., Giustetto C., Bianchi F., Wolpert C., Schimpf R., Riccardi R., et al. Short QT syndrome: a familial cause of sudden death. Circulation. 108:2003;965-970
23. Wilde A.A., Antzelevitch C., Borggrefe M., Brugada J., Brugada R., Brugada P., et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 23:2002;1648-1654
24. Brugada R., Brugada J., Antzelevitch C., Kirsch G.E., Potenza D., Towbin J.A., et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 101:2000;510-515
25. Brugada J., Brugada R., Antzelevitch C., Towbin J., Nademanee K., Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 105:2002;73-78
26. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Giordano U., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 105:2002;1342-1347
27. Jaoude S.A., Leclercq J.F., Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease. Eur Heart J. 11:1996;1717-1722
28. Peters S., Trummel M. Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann Noninvasive Electrocardiol. 3:2003;238-245
29. Benn M., Hansen P.S., Pedersen A.K. QT dispersion in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J. 20:1999;764-770
30. Turrini P., Corrado D., Basso C., Nava A., Bauce B., Thiene G. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation. 103:2001;3075-3080
31. Hokanson J.S., Moller J.H. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot. J Cardiol. 87:2001;1271-1277
32. Gatzoulis M.A., Balaji S., Webber S.A., Siu S.C., Hokanson J.S., Poile C., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 356:2000;975-981
33. Daliento L., Rizzoli G., Menti L., Baratella M.C., Turrini P., Nava A., et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart. 81:1999;650-655
34. Daliento L., Folino A.F., Menti L., Zanco P., Baratella M.C., Dalla Volta S. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot. J Am Coll Cardiol. 38:2001;2043-2047
35. Cecchi F., Olivotto I., Montereggi A., Squillatini G., Dolara A., Maron B.J. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart. 79:1998;331-336
36. Spirito P., Rapezzi C., Autore C., Bruzzi P., Bellone P., Ortolani P., et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 90:1994;2743-2747
37. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol. 42:2003;873-879
38. Maron B.J., Estes N.A. III, Maron M.S., Almquist A.K., Link M.S., Udelson J.E. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 107:2003;2872-2875
39. Boriani G., Rapezzi C., Biffi M., Branzi A., Spirito P. Atrial fibrillation precipitating sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 13:2002;954
40. Favale S., Pappone C., Nacci F., Fino F., Resta F., Dicandia C.D. Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient. Pacing Clin Electrophysiol. 26:2003;637-639
41. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 42:2003;1687-1713
42. Silka M.J. Sudden cardiac death. Balaji S., Gillette P., Case C. Cardiac arrhythmias after surgery for congenital heart disease. 2001;141-153 Arnold, London
43. ACC/AHA Guidelines for Ambulatory Electrocardiography Executive Summary and Recommendations: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) Developed in Collaboration With the North American Society for Pacing and Electrophysiology. Circulation. 100:1999;886-893
44. Cullen S., Celermajer D.S., Franklin R.C., Hallidie-Smith K.A., Deanfield J.E. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J Am Coll Cardiol. 23:1994;1151-1155
45. Kantar R.J., Garson A. Jr. Arrhythmia in congenital heart disease. Podrid P.J., Kowey P.R. Cardiac arrhythmias: mechanisms, diagnosis, management. 1995;1131-1160 Williams & Wilkins, Baltimore (MD)
46. Priori S.G., Aliot E., Blomstrom-Lundqvist C., Bossaert L., Breithardt G., Brugada P., et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 22:2001;1374-1450
47. Kucher D.L. Signal-averaged electrocardiogram in the assessment of cardiac arrhythmias. Podrid P.J., Kowey P.R. Cardiac arrhythmias: mechanisms, diagnosis, management. 1995;247-257 Williams & Wilkins, Baltimore (MD)
48. Hnatkova K., Obel O.A., Camm A.J., Malik M. Technical advances in signal-averaged electrocardiography. Card Electrophysiol Rev. 1(3):1997;317-320
49. Expert Consensus Document Signal-averaged electrocardiography. J Am Coll Cardiol. 27(1):1996;238-249
50. Fallah-Najmabadi H., Dahdah N.S., Palcko M., Mehta S.K. Normal values and methodologic recommendations for signal-averaged electrocardiography in children and adolescents. Am J Cardiol. 77:1996;408-412
51. Vaksmann G., Elkohen M., Duhamel A., Godart F. Signal-averaged electrocardiography in healthy children: influence of age, body size, and gender. Pacing Clin Electrophysiol. 19:1996;1629-1634
52. Nava A., Bauce B., Basso C., Muriago M., Rampazzo A., Villanova C., et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 36:2000;2226-2233
53. Yoshioka N., Tsuchihashi K., Yuda S., Hashimoto A., Uno K., Nakata T., et al. Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and in their pedigrees. Am J Cardiol. 85:2000;885-889
54. Hamid M.S., Norman M., Quraishi A., Firoozi S., Thaman R., Gimeno J.R., et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol. 40:2002;1445-1450
55. Nava A., Folino A.F., Bauce B., Turrini P., Buja G.F., Daliento L., et al. Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias. Eur Heart J. 21(1):2000;58-65
56. Bauce B., Basso C., Nava A. Signal-averaged electrocardiographic parameter progression as a marker of increased electrical instability in two cases with an overt form of arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 25:2002;362-364
57. Nasir K., Crossan J., Baughman K.L., Kasper E.K., Tomaselli G.F., Berger R., et al. Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia. Pacing Clin Electrophysiol. 26:2003;1955-1960
58. Morita H., Takenaka-Morita S., Fukushima-Kusano K., Kobayashi M., Nagase S., Kakishita M., et al. Risk stratification for asymptomatic patients with Brugada syndrome. Circ J. 67:2003;312-316
59. Eckardt L., Bruns H.J., Paul M., Kirchhof P., Schulze-Bahr E., Wichter T., et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol. 13:2002;742-749
60. Ikeda T., Sakurada H., Sakabe K., Sakata T., Takami M., Tezuka N., et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol. 37:2001;1628-1634
61. Tobe T.J., de Langen C.D., Bink-Boelkens M.T., Mook P.H., Viersma J.W., Lie K.I., et al. Late potentials in a bradycardia-dependent long QT syndrome associated with sudden death during sleep. J Am Coll Cardiol. 19:1992;541-549
62. Chang A.C., McAreavey D., Fananapazir L. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death. Curr Opin Cardiol. 10:1995;9-15
63. Englund A., Hnatkova K., Kulakowski P., Elliot P.M., McKenna W.J., Malik M. Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy. Eur Heart J. 19:1998;1383-1390
64. Hiraki T., Ikeda H., Yoshida T., Inage T., Ohe M., Ohtsubo H., et al. P wave signal-averaged electrocardiography predicts recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome who underwent successful catheter ablation: a prospective study. J Cardiovasc Electrophysiol. 13:2002;1003-1008
65. Maia I.G., Cruz Filho F.E., Fagundes M.L., Boghossian S.H., Vanheusden L., Sa R.M., et al. Signal-averaged P wave in patients with Wolff-Parkinson- White syndrome after successful radiofrequency catheter ablation. J Am Coll Cardiol. 26:1995;1310-1314
66. Singh J.P., Larson M.G., O'Donnell C.J., Tsuji H., Evans J.C., Levy D. Heritability of heart rate variability: the Framingham Heart Study. Circulation. 99:1999;2251-2254
67. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 93:1996;1043-1065
68. Silvetti M.S., Drago F., Ragonese P. Heart rate variability in healthy children and adolescents is partially related to age and gender. Int J Cardiol. 81:2001;169-174
69. Umetani K., Singer D.H., McCraty R., Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol. 31:1998;593-601
70. Goto M., Nagashima M., Baba R., Nagano Y., Yokota M., Nishibata K., et al. Analysis of heart rate variability demonstrates effects of development on vagal modulation of heart rate in healthy children. J Pediatr. 130:1997;725-729
71. Bigger J.T. Jr., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Schneider W.J., Stein P.K. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 91:1995;1936-1943
72. Folino A.F., Buja G., Bauce B., Thiene G., dalla Volta S., Nava A. Heart rate variability in arrhythmogenic right ventricular cardiomyopathy correlation with clinical and prognostic features. Pacing Clin Electrophysiol. 25:2002;1285-1292
73. Krittayaphong R., Veerakul G., Nademanee K., Kangkagate C. Heart rate variability in patients with Brugada syndrome in Thailand. Eur Heart J. 24:2003;1771-1778
74. Hermida J.S., Leenhardt A., Cauchemez B., Denjoy I., Jarry G., Mizon F., et al. Decreased nocturnal standard deviation of averaged NN intervals. An independent marker to identify patients at risk in the Brugada syndrome. Eur Heart J. 24:2003;2061-2069
75. Perkiomaki J.S., Zareba W., Couderc J.P., Moss A.J. Heart rate variability in patients with congenital long QT syndrome. Ann Noninvasive Electrocardiol. 6:2001;298-304
76. Doven O., Sayin T., Guldal M., Karaoguz R., Oral D. Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients. Int J Cardiol. 77:2001;281-286
77. Counihan P.J., Fei L., Bashir Y., Farrell T.G., Haywood G.A., McKenna W.J. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation. 88:1993;1682-1690
78. Butera G., Bonnet D., Kachaner J., Sidi D., Villain E. Heart rate variability in children with hypertrophic cardiomyopathy. Heart. 89:2003;205-206
79. Massin M., von Bernuth G. Clinical and haemodynamic correlates of heart rate variability in children with congenital heart disease. Eur J Pediatr. 157:1998;967-971
80. Heragu N.P., Scott W.A. Heart rate variability in healthy children and in those with congenital heart disease both before and after operation. Am J Cardiol. 83:1999;1654-1657
81. Davos C.H., Francis D.P., Leenarts M.F., Yap S.C., Li W., Davlouros P.A., et al. Global impairment of cardiac autonomic nervous activity late after the Fontan operation. Circulation. 108(Suppl 1):2003;II180-II185
82. Davos C.H., Davlouros P.A., Wensel R., Francis D., Davies L.C., Kilner P.J., et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation. 106(Suppl 1):2002;I69-I75
83. Armoundas A.A., Tomaselli G.F., Esperer H.D. Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol. 40:2002;207-217
84. Hohnloser S.H., Klingenheben T., Zabel M., Li Y.G., Albrecht P., Cohen R.J. T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol. 8:1997;987-993
85. Klingenheben T., Hohnloser S.H. Clinical value of T-wave alternans assessment. Card Electrophysiol Rev. 6:2002;323-328
86. Cheung M.M., Davis A.M., Cohen R.J., Wilkinson J.L. T wave alternans threshold in normal children. J Cardiovasc Electrophysiol. 12:2001;424-427
87. Roden D.M., Lazzara R., Rosen M., Schwartz P.J., Towbin J., Vincent G.M. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation. 94:1996;1996-2012
88. Kuroda N., Ohnishi Y., Yoshida A., Kimura A., Yokoyama M. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy. Circ J. 66:2002;457-462
89. Momiyama Y., Hartikainen J., Nagayoshi H., Albrecht P., Kautzner J., Saumarez R.C., et al. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. Jpn Circ J. 61:1997;650-656
90. Cheung M.M., Weintraub R.G., Cohen R.J., Karl T.R., Wilkinson J.L., Davis A.M. T wave alternans threshold late after repair of tetralogy of Fallot. J Cardiovasc Electrophysiol. 13:2002;657-661
91. Gaita F., Giustetto C., Riccardi R., Mangiardi L., Brusca A. Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol. 64:1989;487-490
92. Sharma A.D., Yee R., Guiraudon G., Klein G. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. Am Coll Cardiol. 10:1987;373-381
93. Dillenburg R.F., Hamilton R.M. Is exercise testing useful in identifying congenital long QT syndrome? Am J Cardiol. 89:2002;233-236
94. Paavonen K.J., Swan H., Piippo K., Hokkanen L., Laitinen P., Viitasalo M., et al. Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome. Heart. 86:2001;39-44
95. Katagiri-Kawade M., Ohe T., Arakaki Y., Kurita T., Shimizu W., Kamiya T., et al. Abnormal response to exercise, face immersion, and isoproterenol in children with the long QT syndrome. Pacing Clin Electrophysiol. 18:1995;2128-2134
96. McKenna W.J., Behr E.R. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 87:2002;169-176
97. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 36:2000;2212-2228
98. Akhtar M., Mahmud R., Tchou P., Denker S., Gilbert C.J. Normal electrophysiologic responses of the human heart. Cardiol Clin. 4:1986;365-386
99. Corrado D., Leoni L., Link M.S., Della Bella P., Gaita F., Curnis A., et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation. 108(25):2003;3084-3091
100. Brugada P., Geelen P., Brugada R., Mont L., Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol. 12:2001;1004-1007
101. Brugada P., Brugada R., Mont L., Rivero M., Geelen P., Brugada J. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol. 14:2003;455-457
102. Brugada J., Brugada R., Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation. 108(25):2003;3092-3096
103. Bhandari A.K., Shapiro W.A., Morady F., Shen E.N., Mason J., Scheinman M.M. Electrophysiologic testing in patients with the long QT syndrome. Circulation. 71:1985;63-71
104. Dubin A.M., Collins K.K., Chiesa N., Hanisch D., Van Hare G.F. Use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome. Cardiol Young. 12:2002;248-252
105. Bromberg B.I., Lindsay B.D., Cain M.E., Cox J.L. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 27:1996;690-695
106. Fan W., Peter C.T., Gang E.S., Mandel W. Age-related changes in the clinical and electrophysiologic characteristics of patients with Wolff-Parkinson-White syndrome: comparative study between young and elderly patients. Am Heart J. 122:1991;741-747
107. Brembilla-Perrot B. Age-related changes in arrhythmias and electrophysiologic properties. Card Electrophysiol Rev. 7:2003;88-91
108. Antz M., Weiss C., Volkmer M., Hebe J., Ernst S., Ouyang F., et al. Risk of sudden death after successful accessory atrioventricular pathway ablation in resuscitated patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol. 13:2002;231-236
109. Pappone C., Santinelli V., Manguso F., Augello G., Santinelli O., Vicedomini G., et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. 349:2003;1803-1811
110. Friedli B. Electrophysiological follow-up of tetralogy of Fallot. Pediatr Cardiol. 20:1999;326-330
111. Balaji S., Silka M.J., McAnulty J.H. Arrhythmias in patients with congenital heart disease. Card Electrophysiol Rev. 6:2002;42-44
112. Haemmerli M., Bolens M., Friedli B. Electrophysiological studies after the Mustard and Senning operations for complete transposition. Do they have prognostic value? Int J Cardiol. 27:1990;167-173
113. Behr E.R., Elliott P., McKenna W.J. Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy. Card Electrophysiol Rev. 6:2002;482-486
114. Zhu D.W., Sun H., Hill R., Roberts R. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 21:1998;299-302
115. Begley D.A., Mohiddin S.A., Tripodi D., Winkler J.B., Fananapazir L. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 26:2003;1887-1896
116. Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N., et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol. 40:2002;341-349
117. Pappone C., Santinelli V., Rosanio S., Vicedomini G., Nardi S., Pappone A., et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol. 41:2003;239-244